Scarica l'app Stockscreener
1.34
6.35%
0.08
Pre-mercato:
1.39
0.05
+3.73%
Marker Therapeutics Inc Azioni (MRKR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
43.17%
1.2329
|
0.8612 | 0.3491 | 2.2518 | 1.926 |
Operating Expenses
|
34.21%
3.3697
|
5.1222 | 4.9578 | 6.1132 | 4.3259 |
| Benefits Costs and Expenses |
-
|
- | 4.7953 | 6.0394 | 4.2342 |
| Costs And Expenses |
34.21%
3.3697
|
5.1222 | 4.7953 | 6.0394 | 4.2342 |
| Operating Income/Loss |
49.85%
-2.1367
|
-4.261 | -4.6087 | -3.8614 | -2.3999 |
| Income/Loss From Continuing Operations Before Tax |
43.17%
1.2329
|
0.8612 | -4.4462 | -3.7877 | -2.3082 |
| Income/Loss From Continuing Operations After Tax |
50.23%
-1.9987
|
-4.0156 | -4.4462 | -3.8376 | -2.3082 |
|
Net Income/Loss
|
50.23%
-1.9987
|
-4.0156 | -4.4462 | -3.8376 | -2.3082 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
20.07%
16.76
|
13.96 | 11.11 | 0.0657 | 8.9232 |
| Diluted Average Shares |
20.07%
16.76
|
13.96 | 11.11 | 0.0657 | 8.9232 |
| Basic Earnings Per Share |
58.62%
-0.12
|
-0.29 | -0.40 | -0.42 | -0.26 |
| Diluted Earnings Per Share |
58.62%
-0.12
|
-0.29 | -0.40 | -0.42 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):